Article Information
PubMed
History
- Published online September 12, 2021.
Copyright & Usage
© 2021 CMA Joule Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Mara Sobel, MD MSc,
- Andrea N. Simpson, MD MSc,
- Sarah E. Ferguson, MD
- Department of Obstetrics & Gynaecology (Sobel), Sinai Health System; Department of Obstetrics & Gynaecology (Sobel), Women’s College Hospital; Department of Obstetrics & Gynaecology (Sobel, Simpson, Ferguson), University of Toronto; Department of Obstetrics & Gynaecology (Simpson), St. Michael’s Hospital/Unity Health Toronto; Li Ka Shing Knowledge Institute (Simpson), Unity Health Toronto; Division of Gynecologic Oncology (Ferguson), University Health Network/Sinai Health System, Toronto, Ont.
- Correspondence to: Mara Sobel, Mara.Sobel{at}sinaihealth.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Jump to section
- Article
- Endometrial cancer is the most common gynecologic malignant disease in Canada
- Advancing age and obesity are the key risk factors (Box 1)
- Postmenopausal vaginal bleeding or premenopausal abnormal bleeding is the usual presenting sign
- Patients should be referred to a gynecologist if endometrial biopsy is abnormal, unobtainable or unavailable in primary care, or if postmenopausal or abnormal uterine bleeding persists after a normal biopsy
- With early detection and treatment, prognosis is good
- Footnotes
- References
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.
More in this TOC Section
Similar Articles
Collections
